Literature DB >> 30922047

Human toxocariasis seroprevalence among patients with uveitis in Alborz Province, Iran.

Mohammad Zibaei1, Maryam Alemi2, Natalia Marina Cardillo3, Hamid Derafshi4, Abolfazl Miahipour5, Saeed Bahadory6, Mohammad Zarei7.   

Abstract

INTRODUCTION AND
OBJECTIVE: Toxocariasis, predominantly caused by <i>Toxocara canis</i>, is a common zoonotic parasitosis worldwide. <i>Toxocara</i> infection is a cause of vision impairment and blindness. The presented study investigates the frequency of antibodies against <i>Toxocara</i> among uveitis patients and the epidemiological factors associated with disease.
MATERIAL AND METHODS: Fifty-four patients with uveitis and 59 healthy subjects were studied. Anti-<i>Toxocara</i> antibodies status was determined in all serum samples using enzyme linked immunosorbent assay (ELISA), and seropositive samples analyzed by Western blot (WB) technique.
RESULTS: The frequency of <i>Toxocara canis</i> infection was found to be significantly higher in uveitis patients, compared to healthy controls by the use of ELISA test, being 14.8% and 1.7%, respectively. From 8 seropositive samples, 5 (62.5%) patients exhibited <i>Toxocara</i> immunoglobulin G (IgG) antibodies in response to Western blot, whereas in the control group, none were detected positive by Western blot. No significant difference was found between pet owners, nor between different places of residence. The seroprevalence to Toxocara among uveitis patients was significantly related to gender, age and medical diagnosis. The highest prevalence was found in patients with posterior uveitis (27.8%).
CONCLUSIONS: Anti-<i>Toxocara</i> antibody titers are associated with the risk of vision impairment -uveitis. The risk factor associated with <i>Toxocara</i> exposure identified in this study warrants further investigation.

Entities:  

Keywords:  ELISA; Toxocara canis; Uveitis patients; Western blot; diagnosis; toxocariasis

Mesh:

Substances:

Year:  2019        PMID: 30922047     DOI: 10.26444/aaem/102293

Source DB:  PubMed          Journal:  Ann Agric Environ Med        ISSN: 1232-1966            Impact factor:   1.447


  5 in total

1.  Human Toxocariasis in individuals with blood disorders and cancer patients: the first seroepidemiological study in Iran.

Authors:  Vahid Raissi; Nasrin Sohrabi; Fatemeh Bayat; Soudabeh Etemadi; Omid Raiesi; Pantea Jalali; Maryam Karami; Ali Abdollahi; Ziba Hoseiny; Mahdi Shayanfard; Gita Alizadeh; Mahmoud E Gadalla; Asmaa Ibrahim
Journal:  J Parasit Dis       Date:  2021-01-16

2.  Prevalence of Toxocara and Toxascaris infection among human and animals in Iran with meta-analysis approach.

Authors:  Aida Vafae Eslahi; Milad Badri; Ali Khorshidi; Hamidreza Majidiani; Elham Hooshmand; Hamid Hosseini; Ali Taghipour; Masoud Foroutan; Nader Pestehchian; Farzaneh Firoozeh; Seyed Mohammad Riahi; Mohammad Zibaei
Journal:  BMC Infect Dis       Date:  2020-01-07       Impact factor: 3.090

3.  Frequency of Toxocara Antibodies in Patients Clinically Suspected to Ocular Toxocariasis, Northeast of Iran.

Authors:  Abdolmajid Fata; Seyedeh Maryam Hosseini; Se Joon Woo; Mohammad Zibaei; Fariba Berenji; Bibi Razieh Hosseini Farash; Elham Moghaddas
Journal:  Iran J Parasitol       Date:  2021 Apr-Jun       Impact factor: 1.012

4.  In vitro anti-gastrointestinal cancer activity of Toxocara canis -derived peptide: Analyzing the expression level of factors related to cell proliferation and tumor growth.

Authors:  Saeed Bahadory; Javid Sadraei; Mohammad Zibaei; Majid Pirestani; Abdolhossein Dalimi
Journal:  Front Pharmacol       Date:  2022-09-20       Impact factor: 5.988

5.  Establishment of an Experimental Procedure for Preparing Trial Serum Samples for the Specific Serodiagnosis of Toxocara canis for External Quality Assessment Schemes.

Authors:  Quang Huy Vu; Diep Tuan Tran; Phu Manh Sieu Tran; Van Chuong Le; Thi Diem Phuc Huynh; Quang Sang Bui
Journal:  J Parasitol Res       Date:  2020-02-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.